A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial.
about
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapyCentral pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.The Perfect Pathology Report After Neoadjuvant Therapy.Neoadjuvant chemotherapy in breast cancers.Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function.Pathology vs medical oncology: the crucial exchange of accurate information.The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.MRI and (31)P magnetic resonance spectroscopy hardware for axillary lymph node investigation at 7T.¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.Quality of Breast Cancer Surgical Pathology Reports
P2860
Q33683120-19FAB7E9-82E1-493C-A110-31BCF71CDA01Q35005762-71CB02A1-3911-41BA-A0C9-5D8A2788FD3EQ35782342-10ECCC08-2156-454E-A781-AF86ACFF7382Q35881343-2AD46B15-C95A-4AF6-B9C7-690A6091FFF5Q36584124-055FE239-67A8-45BA-963A-01B6651DBD17Q36793779-AC01E68B-A4BF-4679-8302-A1062CCB9420Q38430990-F0C7E052-E723-45D1-80CD-BDF77E40C7CCQ38524563-B815DA31-0DA6-4B40-87CE-513008EF3788Q39019234-B9EA5494-FE85-4E37-9223-311F19ECFFDEQ41820180-3CC85217-B288-4BBE-AD9D-6951762D7A7DQ43234282-C9D6AEC9-4FB6-4EA5-870A-4AA375631DFFQ48262301-0021F24A-23DF-4267-80AC-8541D1B7C371Q48733630-188AD2E4-AD8B-4E4C-A55F-6B5DC6C75415Q51009203-8A8C4CAC-BF2D-4A9C-B4A0-AB48E7EDBD73Q55131605-7A277CDE-CB89-4F92-8F0E-027D8F2A4AC1
P2860
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A central review of histopatho ...... herapy in the neo-tango trial.
@ast
A central review of histopatho ...... herapy in the neo-tango trial.
@en
type
label
A central review of histopatho ...... herapy in the neo-tango trial.
@ast
A central review of histopatho ...... herapy in the neo-tango trial.
@en
prefLabel
A central review of histopatho ...... herapy in the neo-tango trial.
@ast
A central review of histopatho ...... herapy in the neo-tango trial.
@en
P2093
P2860
P356
P1476
A central review of histopatho ...... herapy in the neo-tango trial.
@en
P2093
A-L Vallier
E Provenzano
M Iddawela
P2860
P2888
P304
P356
10.1038/BJC.2012.547
P407
P577
2013-01-08T00:00:00Z